{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:13:32Z","timestamp":1784657612751,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine, Pharmacy, Science, and Technology","award":["10126\/5\/17.12.2020"],"award-info":[{"award-number":["10126\/5\/17.12.2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: This study evaluated the correlation between hyperferritinemia and markers of liver steatosis, fibrosis, and risk of liver-related events in patients with type 2 diabetes mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Material and Methods: This study included 271 patients that underwent a comprehensive medical evaluation. Hyperferritinemia was defined by values &gt;200 ng\/mL (females) and &gt;300 ng\/mL (males). Liver fibrosis and steatosis were evaluated by several non-invasive indexes, and Liver Risk Score (LRS) was calculated to determine the risk of liver-related events. Their correlation with serum ferritin was investigated by bivariate and multiple regression analyses. Receiver Operating Characteristic (ROC) analyses were used to assess the accuracy to predict advanced fibrosis and increased LRS. Statistical significance was set at p &lt; 0.05. Results: The median serum ferritin level was 94.4 [128.1] ng\/mL. Metabolic hyperferritinemia was present in 12.54% of patients. Patients with hyperferritinemia had higher liver enzymes, HbA1c, HOMA-IR, and increased markers of liver steatosis and fibrosis, with a higher prevalence of advanced fibrosis (OR = 3.744 [1.481, 9.460], p = 0.0081). LRS was highest in patients with hyperferritinemia (7.99 \u00b1 2.01 vs. 7.12 \u00b1 1.32 vs. 6.54 \u00b1 1.06, p &lt; 0.0001). Serum ferritin levels were correlated with LRS (\u03b2 = 0.190 [0.001; 0.003], p &lt; 0.001), liver fibrosis (Fibrotic NASH Index) (\u03b2 = 0.198 [0.000; 0.001], p &lt; 0.001), and steatosis, while haptoglobin concentrations were correlated negatively with them. Serum ferritin predicted the moderate risk of liver-related outcomes with an acceptable performance (area under the ROC curve = 0.726 [0.590; 0.862], p = 0.001). Conclusions: Hyperferritinemia is associated with liver fibrosis and steatosis and a higher risk of liver-related events in patients with T2DM and MASLD.<\/jats:p>","DOI":"10.3390\/medicina61091518","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:32Z","timestamp":1756080572000},"page":"1518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hyperferritinemia and the Risk of Liver Fibrosis and Liver-Related Events in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-6571","authenticated-orcid":false,"given":"Simona","family":"Cernea","sequence":"first","affiliation":[{"name":"Department M3\/Internal Medicine I, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of T\u00e2rgu Mure\u015f, 540142 T\u00e2rgu Mure\u015f, Romania"},{"name":"Diabetes, Nutrition and Metabolic Diseases Outpatient Unit, Emergency County Clinical Hospital, 540136 T\u00e2rgu Mure\u015f, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrada Larisa","family":"Roiban","sequence":"additional","affiliation":[{"name":"Diabetes Compartment, Media\u0219 Municipal Hospital, 551030 Media\u0219, Romania"},{"name":"Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of T\u00e2rgu Mure\u015f, 540142 T\u00e2rgu Mure\u015f, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-9109","authenticated-orcid":false,"given":"Danusia","family":"Oni\u0219or","sequence":"additional","affiliation":[{"name":"Department ME2\/Internal Medicine VII, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u015f, 540142 T\u00e2rgu Mure\u015f, Romania"},{"name":"Gastroenterology Clinic, Mure\u0219 County Clinical Hospital, 540103 T\u00e2rgu Mure\u015f, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e3386","DOI":"10.1002\/dmrr.3386","article-title":"NAFLD in type 2 diabetes mellitus: Still many challenging questions","volume":"37","author":"Cernea","year":"2021","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cernea, S. (2024). NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay. Life, 14.","DOI":"10.3390\/life14020272"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bjh.15166","article-title":"Investigation and management of a raised serum ferritin","volume":"181","author":"Cullis","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Anastasopoulos, N.A., Barbouti, A., Goussia, A.C., Christodoulou, D.K., and Glantzounis, G.K. (2025). Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC). Cancers, 17.","DOI":"10.3390\/cancers17050842"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jdi.13216","article-title":"Iron metabolism and type 2 diabetes mellitus: A meta-analysis and systematic review","volume":"11","author":"Liu","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-physiol-022522-102832","article-title":"Iron and the Pathophysiology of Diabetes","volume":"85","author":"Harrison","year":"2023","journal-title":"Annu. Rev. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jgh3.12019","article-title":"Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease","volume":"1","author":"Saleh","year":"2017","journal-title":"JGH Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-017-0613-4","article-title":"Association of serum ferritin with non-alcoholic fatty liver disease: A meta-analysis","volume":"16","author":"Du","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12944-024-02129-6","article-title":"Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: A prospective cohort study","volume":"23","author":"Song","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.24706","article-title":"Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"55","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gutjnl-2023-330815","article-title":"Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease","volume":"73","author":"Armandi","year":"2024","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41574-023-00807-6","article-title":"Consensus Statement on the definition and classification of metabolic hyperferritinaemia","volume":"19","author":"Valenti","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4330\/wjc.v16.i10.580","article-title":"Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes","volume":"16","author":"Cernea","year":"2024","journal-title":"World J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Oni\u0219or, D., Roiban, A.L., and Cernea, S. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients-The Relationship with Platelets Indicators. Medicina, 60.","DOI":"10.3390\/medicina60122091"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.iliver.2023.10.002","article-title":"Advances in diagnostic ultrasound techniques for assessing liver steatosis in nonalcoholic fatty liver disease","volume":"2","author":"Wang","year":"2023","journal-title":"iLiver"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., and Tiribelli, C. (2006). The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol., 6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jgh.12665","article-title":"Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Otgonsuren","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","article-title":"Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis","volume":"21","author":"Tavaglione","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","year":"2008","journal-title":"Ann. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","article-title":"Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: A multicohort study","volume":"402","author":"Juanola","year":"2023","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.medj.2024.03.003","article-title":"LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population","volume":"5","author":"Liu","year":"2024","journal-title":"Med"},{"key":"ref_30","first-page":"CD011817","article-title":"Serum or plasma ferritin concentration as an index of iron deficiency and overload","volume":"5","author":"Pasricha","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan","year":"2017","journal-title":"Int. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/j.2040-4603.2013.tb00494.x","article-title":"Iron homeostasis in the liver","volume":"3","author":"Anderson","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3748\/wjg.v25.i5.521","article-title":"Iron and liver fibrosis: Mechanistic and clinical aspects","volume":"25","author":"Mehta","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840080218","article-title":"Interactions between isolated hepatocytes and Kupffer cells in iron metabolism: A possible role for ferritin as an iron carrier protein","volume":"8","author":"Sibille","year":"1988","journal-title":"Hepatology"},{"key":"ref_38","first-page":"580A","article-title":"The Role of Receptor-Mediated Endocytosis of H-ferritin in Induction of NFkappaB-dependent Proinflammatory Signalling in Hepatic Stellate Cells: 787","volume":"60","author":"Burgess","year":"2014","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.3748\/wjg.v13.i35.4746","article-title":"Role of iron in hepatic fibrosis: One piece in the puzzle","volume":"13","author":"Philippe","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Guo, W., Weng, T., and Song, Y. (2025). Association of serum iron status with MASLD and liver fibrosis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0319057"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e20231405","DOI":"10.1590\/1806-9282.20231405","article-title":"Association between nonalcoholic steatohepatitis and high serum ferritin levels in type 2 diabetes mellitus","volume":"70","author":"Wang","year":"2024","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s11596-024-2868-0","article-title":"Association between Serum Ferritin Levels and Metabolic-associated Fatty Liver Disease in Adults: A Cross-sectional Study Based on the NHANES","volume":"44","author":"Li","year":"2024","journal-title":"Curr. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/apt.18377","article-title":"A Prospective Study on the Prevalence of MASLD in Patients with Type 2 Diabetes and Hyperferritinaemia","volume":"61","author":"Amangurbanova","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/liv.15787","article-title":"Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease","volume":"44","author":"Suresh","year":"2024","journal-title":"Liver Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/apt.18402","article-title":"Serum Ferritin Levels and Liver-Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study","volume":"61","author":"Song","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12291-023-01159-8","article-title":"Diagnostic Utility of Serum Ferritin in Identifying Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Cross-Sectional Study Using National Health and Nutrition Examination Survey (NHANES-2017-2020) Data","volume":"40","author":"Ramasamy","year":"2025","journal-title":"Indian. J. Clin. Biochem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3138\/canlivj-2021-0002","article-title":"Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis","volume":"5","author":"Trasolini","year":"2022","journal-title":"Can. Liver J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.dsx.2019.05.032","article-title":"Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease","volume":"13","author":"Hanafy","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00125-024-06087-7","article-title":"Surveillance of the liver in type 2 diabetes: Important but unfeasible?","volume":"67","author":"Qadri","year":"2024","journal-title":"Diabetologia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1440-1746.2010.06612.x","article-title":"Biomarkers of liver fibrosis","volume":"26","author":"Adams","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"98807","DOI":"10.5315\/wjh.v11.i3.98807","article-title":"Multifaceted role of haptoglobin: Implications for disease development","volume":"11","author":"Cheng","year":"2024","journal-title":"World J. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e10810","DOI":"10.5812\/hepatmon.10810","article-title":"Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: A pilot study","volume":"13","author":"Alboraie","year":"2013","journal-title":"Hepat. Mon."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3346\/jkms.2010.25.1.67","article-title":"Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease","volume":"25","author":"Lee","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12010-012-0001-5","article-title":"Proteomic identification network analysis of haptoglobin as a key regulator associated with liver fibrosis","volume":"169","author":"Zhang","year":"2013","journal-title":"Appl. Biochem. Biotechnol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:17Z","timestamp":1760034917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091518"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091518","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}